Simplex Trading
WVE icon

Simplex Trading’s Wave Life Sciences WVE Stock Holding History

Simplex Trading’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$881K Sell
121,500
-89,300
-42% -$1.16M ﹤0.01% 2642
2025
Q4 		$3.58M Buy
210,800
+128,800
+157% +$1.31M ﹤0.01% 1530
2025
Q3 		$600K Buy
82,000
+71,800
+704% +$581K ﹤0.01% 3600
2025
Q2 		$66K Sell
10,200
-72,900
-88% -$481K ﹤0.01% 5651
2025
Q1 		$671K Buy
83,100
+5,000
+6% +$54.7K ﹤0.01% 3076
2024
Q4 		$966K Buy
78,100
+43,800
+128% +$585K ﹤0.01% 2875
2024
Q3 		$281K Buy
+34,300
New +$205K ﹤0.01% 4197
2024
Q2 		– Sell
-2,300
Closed -$14K – 9971
2024
Q1 		$14K Sell
2,300
-25,200
-92% -$126K ﹤0.01% 7395
2023
Q4 		$138K Buy
27,500
+25,800
+1,518% +$138K ﹤0.01% 5057
2023
Q3 		$9K Buy
+1,700
New +$7.76K ﹤0.01% 7282
2023
Q2 		– Sell
-400
Closed -$1K – 10089
2023
Q1 		$1K Sell
400
-16,800
-98% -$77K ﹤0.01% 8799
2022
Q4 		$120K Buy
17,200
+2,300
+15% +$10.6K ﹤0.01% 4862
2022
Q3 		$53K Buy
14,900
+11,000
+282% +$36.4K ﹤0.01% 6381
2022
Q2 		$12K Buy
3,900
+2,600
+200% +$5K ﹤0.01% 8154
2022
Q1 		$2K Sell
1,300
-2,000
-61% -$4.9K ﹤0.01% 9959
2021
Q4 		$10K Sell
3,300
-9,200
-74% -$38.2K ﹤0.01% 9063
2021
Q3 		$84K Sell
12,500
-500
-4% -$3.03K ﹤0.01% 6871
2021
Q2 		$86K Buy
13,000
+12,933
+19,303% +$84.5K ﹤0.01% 6950
2021
Q1 		$37K Sell
67
-134
-67% -$1.29K ﹤0.01% 6947
2020
Q4 		$158K Sell
201
-349
-63% -$2.93K ﹤0.01% 4923
2020
Q3 		$466K Buy
550
+548
+27,400% +$6.01K ﹤0.01% 3088
2020
Q2 		$2K Sell
2
-292
-99% -$2.75K ﹤0.01% 7289
2020
Q1 		$275K Sell
294
-233
-44% -$1.99K ﹤0.01% 3232
2019
Q4 		$422K Buy
527
+526
+52,600% +$12.9K ﹤0.01% 2920
2019
Q3 		$2K Sell
1
-25
-96% -$573 ﹤0.01% 6966
2019
Q2 		$67K Buy
+26
New +$729 ﹤0.01% 4587

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Simplex Trading's WVE Position: Q1 2026 in Review

Simplex Trading increased its Wave Life Sciences (WVE) stake by 323% in Q1 2026, buying an estimated $888K and bringing the position to 89,263 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

Simplex Trading first reported a position in WVE in Q1 2019 and has held it in 24 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Simplex Trading held 89,263 shares of Wave Life Sciences worth $647K as of Q1 2026.
  • Simplex Trading bought 68,137 Wave Life Sciences shares in Q1 2026, an estimated $888K.
  • Wave Life Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2969 holding.
  • Simplex Trading first reported a position in Wave Life Sciences in Q1 2019 and has held it in 24 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.